We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
House Democrats have told HHS' acting deputy inspector general (IG) they are not satisfied with her report on an investigation into allegations the Centers for Medicare & Medicaid Services (CMS) withheld from Congress the true cost of the Medicare reform law.
As a means of making it easier for the FDA to inspect institutional review boards (IRBs) and convey information to them, the HHS is proposing that IRBs be required to register at an HHS website.
Rep. Henry Waxman’s charge that the department’s plan for speeding up the approval process for combination AIDS drug therapies will actually delay the products’ availability is wide of the mark, HHS officials say.
HHS’ Centers for Medicare & Medicaid Services (CMS) announced that it is revising its Medicare coverage policy to remove barriers that prevent antiobesity treatments from being covered.
HHS is rebutting Rep. Henry Waxman’s charge that the department’s plan for speeding up the approval process for combination AIDS drug therapies will actually delay the products’ availability.
GlaxoSmithKline (GSK) reversed course and said it would participate in a major clinical trial involving HIV treatment in African and other developing countries, only hours after being chastised by Rep. Henry Waxman (D-Calif.) for dropping out.
An HHS inspector general’s (IG’s) report on allegations that Bush administration officials sought to deliberately withhold from Congress the true cost of the Medicare Prescription Drug, Improvement and Modernization Act badly missed the mark, two ranking Democrats say.
A new report from the Kaiser Commission on Medicaid and the Uninsured concludes that the Medicare prescription drug benefit that kicks off in 2006 could reduce the quantity of Rx drugs prescribed for low-income seniors because of the way the law is structured.
Two ranking House Democrats harshly criticized an HHS inspector general’s (IG’s) report they said largely whitewashes allegations that Bush administration officials sought to deliberately withhold from Congress the true cost of the Medicare Prescription Drug, Improvement and Modernization Act.